Literature DB >> 15876546

The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.

Catharina Wising1, Lena Mölne, Ing-Marie Jonsson, Karin Ahlman, Teresa Lagergård.   

Abstract

Haemophilus ducreyi, the etiologic agent of the sexually transmitted disease chancroid, produces a cytolethal distending toxin (HdCDT) that inhibits cultured cell proliferation, leading to cell death. A rabbit model of dermal infection was used to investigate the roles of H. ducreyi bacteria and HdCDT in the development, clinical appearance, and persistence of infection. A non-toxin producing H. ducreyi strain, and for comparison purposes a non-capsulated Haemophilus influenzae strain, were inoculated intradermally, with and without co-administration of purified HdCDT. Co-administration of HdCDT resulted in significant aggravation of H. ducreyi-induced inflammatory lesions, and development of ulcers in rabbit skin. Less pronounced inflammatory lesions and lack of epithelial eruption were observed after inoculation with H. influenzae. Histopathological sections of the H. ducreyi-induced lesions, in both the presence and absence of HdCDT, showed dense infiltrates of the same type inflammatory cells, with the exception of a prominent endothelial cell proliferation noted in sections from lesions caused by H. ducreyi and toxin. Signs of chronic inflammation with involvement of T cells, macrophages, eosinophils, and granuloma formation were observed after H. ducreyi inoculation both with and without toxin. In conclusion, H. ducreyi causes a pronounced, chronic inflammation with involvement of T cells and macrophages, and in combination with HdCDT production of ulcers in the rabbit model. These pathogenic mechanisms may promote the development and persistence of chancroid ulcers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876546     DOI: 10.1016/j.micinf.2005.02.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  5 in total

1.  Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea.

Authors:  Ayaka Shima; Atsushi Hinenoya; Masahiro Asakura; Norihiko Sugimoto; Teizo Tsukamoto; Hideaki Ito; Akira Nagita; Shah M Faruque; Shinji Yamasaki
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

Review 2.  The biology of the cytolethal distending toxins.

Authors:  Lina Guerra; Ximena Cortes-Bratti; Riccardo Guidi; Teresa Frisan
Journal:  Toxins (Basel)       Date:  2011-03-07       Impact factor: 4.546

3.  Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins.

Authors:  C Bachran; R Hasikova; C E Leysath; I Sastalla; Y Zhang; R J Fattah; S Liu; S H Leppla
Journal:  Cell Death Dis       Date:  2014-01-16       Impact factor: 8.469

Review 4.  Impact of CDT Toxin on Human Diseases.

Authors:  Tiphanie Faïs; Julien Delmas; Arnaud Serres; Richard Bonnet; Guillaume Dalmasso
Journal:  Toxins (Basel)       Date:  2016-07-15       Impact factor: 4.546

Review 5.  Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Authors:  Hendrik Fuchs; Alexander Weng; Roger Gilabert-Oriol
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.